Today: 2 May 2026
Browse Category

NYSE:PLTR 30 December 2025 - 7 January 2026

Palantir stock ticks higher as Truist starts coverage with $223 target, valuation stays in play

Palantir stock ticks higher as Truist starts coverage with $223 target, valuation stays in play

Palantir Technologies shares rose 0.9% to $181.38 Wednesday after Truist initiated coverage with a “buy” rating and a $223 target, citing strong AI-driven revenue growth. The stock traded at over 400 times earnings, raising concerns about high expectations. Investors remained cautious ahead of Friday’s U.S. jobs report, which could impact tech valuations. Palantir’s next earnings are expected Feb. 2.
7 January 2026
·
Palantir stock climbs after Truist opens coverage with $223 target as valuation stays in focus

Palantir stock climbs after Truist opens coverage with $223 target as valuation stays in focus

Palantir shares rose 2.6% to $178.59 Tuesday after Truist Securities initiated coverage with a buy rating and a $223 target. The move follows a 130% gain in 2025, drawing attention to the stock’s high valuation. Analysts’ average target is $186.81, with most rating it “hold.” Investors await Palantir’s next earnings date and Friday’s U.S. jobs report.
6 January 2026
··
Palantir stock jumps nearly 4% after early-year swoon as traders eye jobs report, earnings

Palantir stock jumps nearly 4% after early-year swoon as traders eye jobs report, earnings

Palantir Technologies shares rose 3.7% to $174.04 Monday, recovering from a 5.6% drop Friday after a company officer filed to sell up to 12,000 shares. The stock traded between $166.35 and $181.35 during the session and was little changed after hours. Investors are watching Friday’s U.S. jobs report and Palantir’s next earnings, expected in early February.
5 January 2026
··
Palantir vs Oracle: Wall Street’s AI stock split — and 3 alternatives investors are watching in 2026

Palantir vs Oracle: Wall Street’s AI stock split — and 3 alternatives investors are watching in 2026

Wall Street analysts remain neutral on Palantir, citing its high valuation, while seeing more upside in Oracle as AI-related costs rise, according to a Motley Fool analysis. Palantir shares closed at $167.86, down 5.6%, and Oracle at $195.71, up 0.4%. Investors are weighing risks tied to surging chip and power expenses. Alternatives highlighted include Alphabet, Micron, and Nvidia.
5 January 2026
····
Surf Air Mobility stock jumps again in premarket after SurfOS update — what to watch next

Surf Air Mobility stock jumps again in premarket after SurfOS update — what to watch next

Surf Air Mobility (SRFM) climbed about 10% to $2.63 in premarket trading Monday, extending Friday’s 23% surge after announcing $26 million in SurfOS funding and an expanded Palantir partnership. The company’s stock traded above its previous high of $2.43, with investors watching if momentum holds ahead of earnings on March 26.
5 January 2026
·····
Palantir stock drops 5% today as 2026 kicks off; PLTR slips below key technical levels

Palantir stock drops 5% today as 2026 kicks off; PLTR slips below key technical levels

Palantir shares dropped 5.2% to $168.43 in the first session of 2026, with nearly 50 million shares traded. The decline followed a 136% gain in 2025 and came as investors rotated out of software stocks and into chipmakers, sending the Philadelphia Semiconductor index up 3.5%. No new Palantir announcement drove the move. Traders are watching upcoming U.S. jobs data and Palantir’s next quarterly report.
2 January 2026
·
Palantir stock dips today as 2026 trading begins — what traders are watching next for PLTR

Palantir stock dips today as 2026 trading begins — what traders are watching next for PLTR

Palantir shares fell 0.4% to $177.04 Friday morning, trailing gains in the broader tech sector as the Nasdaq-tracking QQQ rose 1.1%. The stock remains about 15% below its 52-week high, with investors watching valuation metrics ahead of an expected early-February earnings report. AI-linked software stocks traded mixed, and focus remains on updates for Palantir’s commercial AI adoption.
2 January 2026
·
Palantir stock today: PLTR edges lower as Fed minutes and year-end trading test the AI rally

Palantir stock today: PLTR edges lower as Fed minutes and year-end trading test the AI rally

Palantir shares slipped 0.4% to $180.18 midday Wednesday, mirroring a modest drop in U.S. stocks after the Fed’s meeting minutes signaled a cautious 2026 rate outlook. Wedbush named Palantir a top AI pick for 2026 with a $230 target. The stock is up about 140% in 2025. Volume reached 8.8 million shares as investors awaited the next Fed meeting and Palantir’s earnings date.
31 December 2025
····
Palantir stock slips today as Fed minutes loom and AI-linked tech cools

Palantir stock slips today as Fed minutes loom and AI-linked tech cools

Palantir shares fell 0.7% to $182.91 in early Tuesday trading as investors trimmed exposure to AI-linked software stocks. The drop followed a 2.4% decline Monday amid broader tech weakness. Markets remain focused on upcoming Federal Reserve meeting minutes for direction in a thin year-end week. CEO Alex Karp’s nontraditional hiring push drew renewed attention after a report on the company’s paid fellowship for high school graduates.
30 December 2025
···
S&P 500 flatlines into year-end as Fed minutes loom; Meta’s AI buy, Boeing contract in focus

S&P 500 flatlines into year-end as Fed minutes loom; Meta’s AI buy, Boeing contract in focus

Wall Street’s main indexes opened slightly lower Tuesday, with the Dow down 27 points after tech stocks dragged markets in the previous session. Gold and silver rebounded following a margin hike that triggered a sharp drop Monday. Meta rose 1% after announcing a $2–3 billion AI startup deal. Investors await Fed minutes for signals on 2026 rate policy.
30 December 2025
·······
1 … 4 5 6 7 8 … 12

Stock Market Today

  • GLP-1 Weight Loss Drugs Spark Growing Market for Hair Treatment Products
    May 2, 2026, 11:12 AM EDT. GLP-1 drugs, widely used for weight loss, have a common side effect: hair loss, fueling a rising demand for targeted hair treatment products. Brands like Redken, Nutrafol, and KeraFactor are innovating and marketing treatments aimed at users experiencing hair thinning due to rapid weight loss induced by these medications. Retailers such as Ulta report increased customer interest in such products. Experts highlight the merging of health, wellness, and beauty as a significant investment opportunity. With GLP-1 use doubling since early 2024 and projections estimating 25 million American users by 2030, the market for hair care solutions linked to these drugs is set to expand considerably.

Latest article

Wolfspeed Stock Just Jumped 25% Before Earnings. The Hard Part Comes Tuesday

Wolfspeed Stock Just Jumped 25% Before Earnings. The Hard Part Comes Tuesday

2 May 2026
Wolfspeed shares surged nearly 25% Friday, closing at $36.76 after Capital Ventures International and Susquehanna disclosed a 5% stake. The company, which exited Chapter 11 last year, will report fiscal Q3 earnings May 5. Wolfspeed recently raised $475.9 million to reduce debt but continues to post losses amid weak EV demand and rising competition from larger chipmakers.
Stryker Corporation Stock Slides After Cyberattack Hits Q1 Earnings — Why the 2026 Outlook Still Holds

Stryker Corporation Stock Slides After Cyberattack Hits Q1 Earnings — Why the 2026 Outlook Still Holds

2 May 2026
Stryker missed first-quarter profit and revenue estimates after a March cyberattack disrupted operations, reporting net sales of $6.0 billion and adjusted earnings per share of $2.60. Shares fell 6.47% to $294.73 on May 1. The company said the incident had a material impact on the quarter but kept its 2026 outlook unchanged. Some delayed sales and procedures may shift into later quarters.
Salesforce Stock Jumps as Agentforce AI Revenue Scorecard Gets a Reset

Salesforce Stock Jumps as Agentforce AI Revenue Scorecard Gets a Reset

2 May 2026
Salesforce will split AI-era revenue into two main categories, Agentforce Apps and Data 360, starting fiscal 2027. Shares rose 4.13% to $183.82 after the announcement. Recast fiscal 2026 data shows Agentforce Apps brought in $26.7 billion, while Data 360, Platform & Other generated $12.7 billion. The company will provide recast data for fiscal 2025 and 2026 to allow year-over-year comparisons.
Go toTop